Trial Profile
Clinical Trials Insight: 700028303
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2007
Price :
$35
*
At a glance
- Drugs GS 6201 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease; Pulmonary fibrosis; Respiratory tract disorders
- Focus Adverse reactions
- Sponsors CV Therapeutics
- 09 Nov 2007 New trial record.